Enanta Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Enanta Pharma (ENTA).

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

1S.Buy

5Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$19Upside to Avg. PT+58.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$20
Jun 23, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$20
Feb 10, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$20
Jan 9, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$20
Nov 14, 2025	JP Morgan	Anupam Rama	Initiate	Overweight	$17
Sep 30, 2025	WestPark Capital	Ed Arce	PT Raise	Buy	$24→$28
Sep 15, 2025	Evercore ISI Group	Liisa Bayko	PT Cut	Outperform	$20→$12
Sep 2, 2025	WestPark Capital	Ed Arce	Initiate	Buy	$24
Aug 12, 2025	JMP Securities	Roy Buchanan	PT Raise	Market Outperform	$24→$25
Jul 28, 2025	HC Wainwright & Co.	Brandon Folkes	Assumes	Buy	$20
Jun 3, 2025	JMP Securities	Roy Buchanan	PT Raise	Market Outperform	$23→$24
May 14, 2025	JMP Securities	Roy Buchanan	PT Raise	Market Outperform	$21→$23
Feb 11, 2025	JMP Securities	Roy Buchanan	Maintained	Market Outperform	$21
Feb 11, 2025	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$18
Dec 24, 2024	HC Wainwright & Co.	Ed Arce	PT Cut	Buy	$27→$18
Nov 26, 2024	Baird	Brian Skorney	PT Cut	Outperform	$26→$20
Nov 26, 2024	JMP Securities	Roy Buchanan	PT Cut	Market Outperform	$22→$21
Oct 10, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$27
Oct 9, 2024	JMP Securities	Roy Buchanan	Maintained	Market Outperform	$22
Sep 27, 2024	JMP Securities	Roy Buchanan	Maintained	Market Outperform	$22

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Enanta Pharma (NASDAQ:ENTA) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Enanta Pharma (NASDAQ:ENTA) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Enanta Pharma (NASDAQ:ENTA) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Enanta Pharma (NASDAQ:ENTA) with a Buy and maintains $20 price target.

Benzinga Newsdesk

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday

Avi Kapoor

PRO
JP Morgan Initiates Coverage On Enanta Pharma with Overweight Rating, Announces Price Target of $17

JP Morgan analyst Anupam Rama initiates coverage on Enanta Pharma (NASDAQ:ENTA) with a Overweight rating and announces Price Target of $17.

Benzinga Newsdesk

Enanta Pharmaceuticals Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Enanta Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday

PRO
JP Morgan Initiates Coverage On Enanta Pharma with Overweight Rating, Announces Price Target of $17

People Also Watch

People Also Watch

Enanta Pharmaceuticals Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Enanta Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PROHC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PROHC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PROHC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday

PROJP Morgan Initiates Coverage On Enanta Pharma with Overweight Rating, Announces Price Target of $17

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price Target

PRO
JP Morgan Initiates Coverage On Enanta Pharma with Overweight Rating, Announces Price Target of $17